Molina Healthcare (MOH) Research & Development (2010 - 2018)

Molina Healthcare (MOH) has reported Research & Development for 9 consecutive years, with $120.0 million the latest figure, recorded in Q1 2018.

• Quarterly Research & Development fell 1.64% year-over-year to $120.0 million in Q1 2018, while the trailing twelve-month figure through Mar 2018 was $490.0 million (up 2.08% YoY) and the FY2017 annual result came in at $492.0 million, up 1.44% from the prior year.
• Research & Development eased to $120.0 million in Q1 2018 per MOH's latest filing, from $123.0 million in the prior quarter.
• Over the last five years, Research & Development for MOH reached as high as $127.0 million in Q1 2016 and fell as low as $33.0 million in Q2 2015.
• A 5-year average of $85.1 million and a median of $116.0 million in 2016 frame the typical range for Research & Development.
• Annual changes were most pronounced in 2015 — Research & Development fell 15.14% — and 2016, when it soared 252.78%.
• Year by year, Research & Development stood at $39.2 million in 2014, then jumped by 129.77% to $90.0 million in 2015, then soared by 36.67% to $123.0 million in 2016, then changed by 0.0% to $123.0 million in 2017, then retreated by 2.44% to $120.0 million in 2018.
• According to Business Quant data, Research & Development over the past three periods registered $120.0 million, $123.0 million, and $123.0 million for Q1 2018, Q4 2017, and Q3 2017 respectively.